
March 6 (Reuters) - Day One Biopharmaceuticals Inc DAWN.O:
SERVIER AND DAY ONE BIOPHARMACEUTICALS ANNOUNCE ACQUISITION TO EXPAND SERVIER’S RARE ONCOLOGY PORTFOLIO
DAY ONE BIOPHARMACEUTICALS INC - SERVIER TO BUY DAY ONE FOR $21.50 PER SHARE, TOTAL EQUITY VALUE $2.5 BILLION
DAY ONE BIOPHARMACEUTICALS INC - SERVIER EXPECTS TO FUND DEAL THROUGH EXISTING CASH AND INVESTMENTS